184 related articles for article (PubMed ID: 34268865)
1. In Vivo Tracking of Cell Viability for Adoptive Natural Killer Cell-Based Immunotherapy by Ratiometric NIR-II Fluorescence Imaging.
Liao N; Su L; Zheng Y; Zhao B; Wu M; Zhang D; Yang H; Liu X; Song J
Angew Chem Int Ed Engl; 2021 Sep; 60(38):20888-20896. PubMed ID: 34268865
[TBL] [Abstract][Full Text] [Related]
2. Tracking Cell Viability for Adipose-Derived Mesenchymal Stem Cell-Based Therapy by Quantitative Fluorescence Imaging in the Second Near-Infrared Window.
Liao N; Su L; Cao Y; Qiu L; Xie R; Peng F; Cai Z; Liu X; Song J; Zeng Y
ACS Nano; 2022 Feb; 16(2):2889-2900. PubMed ID: 35084178
[TBL] [Abstract][Full Text] [Related]
3. Real-Time Tracking of
Uong TNT; Lee KH; Ahn SJ; Kim KW; Min JJ; Hyun H; Yoon MS
Front Immunol; 2018; 9():825. PubMed ID: 29770131
[TBL] [Abstract][Full Text] [Related]
4. Tracking adoptive natural killer cells via ultrasound imaging assisted with nanobubbles.
Jiang Y; Hou X; Zhao X; Jing J; Sun L
Acta Biomater; 2023 Oct; 169():542-555. PubMed ID: 37536495
[TBL] [Abstract][Full Text] [Related]
5. Multifunctional nanoparticles for genetic engineering and bioimaging of natural killer (NK) cell therapeutics.
Kim KS; Han JH; Park JH; Kim HK; Choi SH; Kim GR; Song H; An HJ; Han DK; Park W; Park KS
Biomaterials; 2019 Nov; 221():119418. PubMed ID: 31419655
[TBL] [Abstract][Full Text] [Related]
6. Single Wavelength Laser Excitation Ratiometric NIR-II Fluorescent Probe for Molecule Imaging in Vivo.
Ge X; Lou Y; Su L; Chen B; Guo Z; Gao S; Zhang W; Chen T; Song J; Yang H
Anal Chem; 2020 Apr; 92(8):6111-6120. PubMed ID: 32216270
[TBL] [Abstract][Full Text] [Related]
7. Near-infrared emitting fluorescent nanocrystals-labeled natural killer cells as a platform technology for the optical imaging of immunotherapeutic cells-based cancer therapy.
Lim YT; Cho MY; Noh YW; Chung JW; Chung BH
Nanotechnology; 2009 Nov; 20(47):475102. PubMed ID: 19875875
[TBL] [Abstract][Full Text] [Related]
8. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive In Vivo Fluorescence Imaging of NK Cells in Preclinical Models of Adoptive Immunotherapy.
Somanchi SS
Methods Mol Biol; 2016; 1441():307-16. PubMed ID: 27177677
[TBL] [Abstract][Full Text] [Related]
10.
Wang C; Niu M; Wang W; Su L; Feng H; Lin H; Ge X; Wu R; Li Q; Liu J; Yang H; Song J
Anal Chem; 2021 Jul; 93(27):9356-9363. PubMed ID: 34192871
[TBL] [Abstract][Full Text] [Related]
11. Ex vivo expansion of the highly cytotoxic human natural killer-92 cell-line under current good manufacturing practice conditions for clinical adoptive cellular immunotherapy.
Tam YK; Martinson JA; Doligosa K; Klingemann HG
Cytotherapy; 2003; 5(3):259-72. PubMed ID: 12850795
[TBL] [Abstract][Full Text] [Related]
12. Natural killer cell-based adoptive immunotherapy eradicates and drives differentiation of chemoresistant bladder cancer stem-like cells.
Ferreira-Teixeira M; Paiva-Oliveira D; Parada B; Alves V; Sousa V; Chijioke O; Münz C; Reis F; Rodrigues-Santos P; Gomes C
BMC Med; 2016 Oct; 14(1):163. PubMed ID: 27769244
[TBL] [Abstract][Full Text] [Related]
13. Cytokine-induced memory-like natural killer cells have enhanced function, proliferation, and in vivo expansion against ovarian cancer cells.
Uppendahl LD; Felices M; Bendzick L; Ryan C; Kodal B; Hinderlie P; Boylan KLM; Skubitz APN; Miller JS; Geller MA
Gynecol Oncol; 2019 Apr; 153(1):149-157. PubMed ID: 30658847
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of therapeutic effects of natural killer (NK) cell-based immunotherapy in mice using in vivo apoptosis bioimaging with a caspase-3 sensor.
Lee HW; Singh TD; Lee SW; Ha JH; Rehemtulla A; Ahn BC; Jeon YH; Lee J
FASEB J; 2014 Jul; 28(7):2932-41. PubMed ID: 24736413
[TBL] [Abstract][Full Text] [Related]
15. Optical imaging of cellular immunotherapy against prostate cancer.
Tavri S; Jha P; Meier R; Henning TD; Müller T; Hostetter D; Knopp C; Johansson M; Reinhart V; Boddington S; Sista A; Wels WS; Daldrup-Link HE
Mol Imaging; 2009; 8(1):15-26. PubMed ID: 19344572
[TBL] [Abstract][Full Text] [Related]
16. Gold-seaurchin based immunomodulator enabling photothermal intervention and αCD16 transfection to boost NK cell adoptive immunotherapy.
Lin X; Li F; Gu Q; Wang X; Zheng Y; Li J; Guan J; Yao C; Liu X
Acta Biomater; 2022 Jul; 146():406-420. PubMed ID: 35470078
[TBL] [Abstract][Full Text] [Related]
17. Harnessing Natural Killer Cell Antitumor Immunity: From the Bench to Bedside.
Woan KV; Miller JS
Cancer Immunol Res; 2019 Nov; 7(11):1742-1747. PubMed ID: 31676567
[TBL] [Abstract][Full Text] [Related]
18. Ratiometric Imaging of MMP-2 Activity Facilitates Tumor Detection Using Activatable Near-Infrared Fluorescent Semiconducting Polymer Nanoparticles.
Zeng W; Wu L; Sun Y; Wang Y; Wang J; Ye D
Small; 2021 Sep; 17(36):e2101924. PubMed ID: 34309199
[TBL] [Abstract][Full Text] [Related]
19. hIL-15 gene-modified human natural killer cells (NKL-IL15) augments the anti-human hepatocellular carcinoma effect in vivo.
Jiang W; Zhang C; Tian Z; Zhang J
Immunobiology; 2014 Jul; 219(7):547-53. PubMed ID: 24721706
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
